Focus: Infection Control

Chinese city plans to build coronavirus hospital in days

Wuhan is constructing a 1,000-bed facility with prefab buildings


The Chinese city of Wuhan is working to build a 1,000-bed hospital in just 10 days to treat victims of the epidemic, according to an article on the Guardian website.

The hospital is being built with prefabricated buildings around a vacation complex on the outskirts of the city.

China has a history of constructing hospitals at short notice in response to major health crises. 

In 2003, during the SARAS outbreak 7,000 workers in Beijing built the Xiaotangshan hospital in the northern suburbs in a week.

Read the article.

 



January 30, 2020


Topic Area: Infection Control


Recent Posts

Optimizing the Engineering Design of Ambulatory Care Facilities

Designing cost-effective engineering systems is not about minimizing investment but about investing strategically.


Construction Completed on Washington Health Urgent Care Facility in California

The design team maximized the existing footprint to accommodate five exam rooms, a dedicated procedure room and an X-ray room.


OhioHealth Pickerington Methodist Hospital Begins Expansion Project

It includes an expansion of the emergency department (ED) and an additional inpatient unit.


IAQ and Infection Mitigation: Plans Into Actions

To support quality patient care and ensure compliance, managers must stay ahead of environmental and IAQ risks.


Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy

Although the damage was severe, it provided a valuable opportunity for NYU Langone to assess structural vulnerabilities and increase facility resilience.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.